These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8744169)

  • 1. Dangerous hyperglycemia associated with electroconvulsive therapy.
    Reddy S; Nobler MS
    Convuls Ther; 1996 Jun; 12(2):99-103. PubMed ID: 8744169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, efficacy, and effects on glycemic control of electroconvulsive therapy in insulin-requiring type 2 diabetic patients.
    Netzel PJ; Mueller PS; Rummans TA; Rasmussen KG; Pankratz VS; Lohse CM
    J ECT; 2002 Mar; 18(1):16-21. PubMed ID: 11925516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the role of incretin mimetic therapy in the management of type 2 diabetes.
    Unger J; Nadeau DA
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S4-S10. PubMed ID: 18664341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of post-prandial blood glucose excursions in type 1 and type 2 diabetes mellitus.
    Slama G
    Int J Clin Pract Suppl; 2000 Sep; (112):9-12. PubMed ID: 11064945
    [No Abstract]   [Full Text] [Related]  

  • 5. Antidiabetic therapy before and 1 year after discharge for patients manifesting in-hospital hyperglycemia.
    Waddell M; Flanders SJ; Golas A; Zhang Q; Juneja R
    Postgrad Med; 2009 May; 121(3):61-6. PubMed ID: 19491541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hyperglycemia in adult-onset diabetes mellitus].
    Yki-Järvinen H
    Duodecim; 1999; 115(10):1155-64. PubMed ID: 11877855
    [No Abstract]   [Full Text] [Related]  

  • 7. Gestational diabetes: the significance of persistent fasting hyperglycemia for the subsequent development of diabetes mellitus.
    Cheung NW; Helmink D
    J Diabetes Complications; 2006; 20(1):21-5. PubMed ID: 16389163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M; Orsini-Federici M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Stratton IM; Matthews DR
    Diabet Med; 1997 Aug; 14(8):709-10. PubMed ID: 9272603
    [No Abstract]   [Full Text] [Related]  

  • 10. Causes and consequences of hyperglycemia in critical illness.
    Falciglia M
    Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):498-503. PubMed ID: 17563470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the Early Diabetes Intervention Program.
    Kirkman MS; Shankar RR; Shankar S; Shen C; Brizendine E; Baron A; McGill J
    Diabetes Care; 2006 Sep; 29(9):2095-101. PubMed ID: 16936159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ECT on diabetes mellitus. An attempt to account for conflicting data.
    Finestone DH; Weiner RD
    Acta Psychiatr Scand; 1984 Oct; 70(4):321-6. PubMed ID: 6496156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy for type 2 diabetes mellitus.
    Elson DF; Meredith M
    WMJ; 1998 Mar; 97(3):49-54. PubMed ID: 9540451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB; Fonseca VA; Truitt KE; Jones MR
    Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary combined oral antidiabetic therapy in type-2 diabetes mellitus].
    Winkler G; Baranyi E
    Orv Hetil; 2002 Oct; 143(43):2441-7. PubMed ID: 12455146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetes mellitus, but which type?].
    Hoekstra JB; de Koning EJ
    Ned Tijdschr Geneeskd; 2004 Apr; 148(16):761-4. PubMed ID: 15129562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
    Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
    J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin strategies for managing inpatient and outpatient hyperglycemia and diabetes.
    Moghissi ES
    Mt Sinai J Med; 2008 Dec; 75(6):558-66. PubMed ID: 19021195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of insulin therapy on macrovascular risk factors in type 2 diabetes.
    Boyne MS; Saudek CD
    Diabetes Care; 1999 Apr; 22 Suppl 3():C45-53. PubMed ID: 10189562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.